InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,477.90
(
0.16%
)
US TECH 100
19,129.60
(
-0.24%
)
Dow Jones
39,127.80
(
0.04%
)
Brent Oil
84.29
(
-0.22%
)
Bitcoin
61,058.82
(
0.40%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Just the facts maam

Send PM Follow Ignore
Followers 20
Posts 5376
Boards Moderated 0
Alias Born 01/04/2012

Just the facts maam

Re: None

Tuesday, 01/31/2012 8:22:01 PM

Tuesday, January 31, 2012 8:22:01 PM

Post# of 26138
Why BPAX cannot walk away from Libigel.

Interesting article about a presentation given in November 2011 by Professor Susan Davis at international meetings reporting on the research undertaken within the Women's Health Research Program regarding the effectiveness and safety of testosterone therapy for women

Professor Susan Davis is also heading the cognitive study of Libigel in Australia.

Testosterone in women

Female Viagra or not, a safe delivery method for Testosterone is required.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up